-transparent.png){kind=logo}
This study was undertaken to determine if substitution of naproxen for ASA does influence salicylate-induced gastrointestinal bleeding. Twelve normal volunteers were selected and given increasing doses of salicylate until guaiac tests were consistently positive. Autologous labeling of their red blood cells with 51-Cr was used to quantitate the microbleeding. After two weeks on ASA, six subjects were double blindly switched to naproxen and six to placebo for another two weeks of observation. Two-way analysis of variance on the raw data shows a significant treatment effect associated with a significant interaction in both groups. Final analysis on a logarithmic scale permits orthogonal contrasts to be accurately made without any significant remaining interaction. It is concluded that substitution of naproxen for ASA at a dose of 500 mg daily is accompanied by a rapid reduction of microbleeding to "normal" levels.
A Arsenault, and
J Varady, and
E LeBel, and
A Lussier
December 1995,
Alimentary pharmacology & therapeutics,
A Arsenault, and
J Varady, and
E LeBel, and
A Lussier
January 1977,
Journal of pharmaceutical sciences,
A Arsenault, and
J Varady, and
E LeBel, and
A Lussier
January 1984,
Journal of clinical pharmacology,
A Arsenault, and
J Varady, and
E LeBel, and
A Lussier
May 1984,
Clinical pharmacology and therapeutics,
A Arsenault, and
J Varady, and
E LeBel, and
A Lussier
February 1973,
Toxicology and applied pharmacology,
A Arsenault, and
J Varady, and
E LeBel, and
A Lussier
January 1973,
Clinical pharmacology and therapeutics,
A Arsenault, and
J Varady, and
E LeBel, and
A Lussier
July 1987,
Clinical pharmacology and therapeutics,
A Arsenault, and
J Varady, and
E LeBel, and
A Lussier
January 1979,
The Journal of pharmacy and pharmacology,
A Arsenault, and
J Varady, and
E LeBel, and
A Lussier
December 1976,
The American journal of digestive diseases,
A Arsenault, and
J Varady, and
E LeBel, and
A Lussier
January 1998,
Drug metabolism and drug interactions,
